Answers are grounded in this paper and cite their sources.
Fungi can produce a variety of secondary metabolites (SMs), which are among the important sources of bioactive compounds either to be directly developed or as the lead components of pharmaceuticals, agrochemicals, cosmetics and food additives. Fungal monoculture generally hampers metabolite production due to the increased metabolic burden, gene silencing, and limited chemical diversity and scalability. In contrast, fungal–fungal co-cultivation is an effective strategy to induce biosynthesis of SMs by activating cryptic or low-expressing biosynthetic gene clusters. This review summarizes the production of new SMs triggered by fungal–fungal co-cultivation in the latest two decades. The co-cultivated fungi mainly included the species of Alternaria, Aspergillus, Colletotrichum, Fusarium, Nigrospora, Penicillium, and Trichoderma. A total of 387 new SMs, including polyketides, aliphatics, phenolics, steroids, terpenoids and alkaloids with various biological activities, have been revealed from the co-cultures of eighty co-cultivated fungal species. The regulation mechanisms involved in the activation and inhibition of secondary metabolism in fungal–fungal co-cultivation, as well as the applications and prospects of SMs, are also discussed.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: